Merck Sharp & Dohme and Wayra UK Launch Second Call for Digital Health Startups

logo_wayra-1Merck Sharp & Dohme Ltd (MSD), a global healthcare company, and Wayra UK, part of Telefonica Open Future, have opened the second call for digital healthcare startups.

For 2017, Velocity Health will launch two verticals to support startups developing technologies that support those living with lifelong health conditions:
– Living with and Beyond Cancer will help support people affected by cancer to self-manage their recovery, while
– Delivering on Diabetes will aim to improve the treatment and care received by people living with Type 2 Diabetes.

Launched in 2015, the Velocity Health accelerator invests in digital innovations that seek to address the challenges outlined in the NHS Five Year Forward View, a strategy detailing how the NHS can improve patient outcomes, while closing a funding gap that is estimated at £30bn.
A selected number of startups will be chosen to take up the 10-month program, which will provide a total of £64K in investment each. It will include 50% funds and the rest made up of dedicated acceleration services such as access to a network of mentors, coaches and investors, office space within Wayra UK’s new acceleration facility in Central London and potentially, access to Telefonica’s customer base (more than 300 million) and MSD’s networks locally and globally.

The call for Velocity Health start-ups is now open via Applications for start-ups close 17th October.




Join the discussion